C07F9/02

Ligand compound, organic chromium compound, catalyst system for oligomerization of olefins, and method for oligomerization of olefins using the catalyst system

The present invention relates to a ligand compound, a catalyst system for oligomerization of olefins, and a method for oligomerization of olefins using the catalyst system. The catalyst system for oligomerization of olefins according to the present invention not only has excellent catalytic activity, but also exhibits high selectivity to 1-hexene or 1-octene, thus enabling more efficient preparation of alpha-olefin.

Ligand compound, organic chromium compound, catalyst system for oligomerization of olefins, and method for oligomerization of olefins using the catalyst system

The present invention relates to a ligand compound, a catalyst system for oligomerization of olefins, and a method for oligomerization of olefins using the catalyst system. The catalyst system for oligomerization of olefins according to the present invention not only has excellent catalytic activity, but also exhibits high selectivity to 1-hexene or 1-octene, thus enabling more efficient preparation of alpha-olefin.

Phosphorus control for waste streams from glyphosate manufacturing processes

This invention relates to processes for the removal of phosphorous from aqueous waste streams comprising phosphorus-containing compounds produced in the manufacture of glyphosate, in order to meet and typically exceed environmental regulations. More particularly, various embodiments of the present invention relate to the removal of phosphorous-containing compounds utilizing biological treatment system(s), oxidizing agent(s), and/or precipitant(s). The processes of the invention are also applicable to the removal of phosphorous compounds from phosphorous-containing waste streams other than those waste streams resulting from the manufacture of glyphosate.

POLYMORPH OF SODIUM NERIDRONATE AND PREPARATION PROCESS THEREOF

The present invention relates to a novel crystalline hemihydrate polymorph of neridronic acid sodium salt, and a novel process for the preparation thereof comprising the steps of: 1) dissolving solid sodium neridronate in any crystalline form in water, at a temperature in the range from 70 to 90 C., to obtain an aqueous solution of sodium neridronate; 2) adding a solvent selected from the group consisting in ethanol, 1-propanol, and 2-propanol to the aqueous solution obtained from step (1), so that the final water:solvent volume ratio is in the range from 1:0.5 to 1:1, thus obtaining a suspension; 3) placing the suspension obtained from step (2) under mechanical stirring, at a temperature in the range from 60 to 95 C.; 4) recovering the crystalline hemihydrate form F of sodium neridronate formed in the previous step (3). The crystalline hemihydrate form F of sodium neridronate, particularly stable, may be employed in the preparation of solid oral pharmaceutical forms for use in the treatment of musculoskeletal and calcium metabolism disorders.

Liquid electrolyte, and method for manufacturing phosphate

An electrolyte solution capable of providing electrochemical devices whose internal resistance is less likely to increase even after repeated charge and discharge and whose cycle capacity retention ratio is high. The electrolyte solution contains a solvent, an electrolyte salt, and a phosphate in an amount of 0.001 to 15 mass % relative to the solvent and represented by the formula (1): (R.sup.11O)(R.sup.12O)PO.sub.2M, where R.sup.11, R.sup.12 and M are as defined herein.

Liquid electrolyte, and method for manufacturing phosphate

An electrolyte solution capable of providing electrochemical devices whose internal resistance is less likely to increase even after repeated charge and discharge and whose cycle capacity retention ratio is high. The electrolyte solution contains a solvent, an electrolyte salt, and a phosphate in an amount of 0.001 to 15 mass % relative to the solvent and represented by the formula (1): (R.sup.11O)(R.sup.12O)PO.sub.2M, where R.sup.11, R.sup.12 and M are as defined herein.

Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-YL) piperidin-1-YL]phenyl}pyrimidine-2,4-diamine

Crystalline forms of brigatinib, pharmaceutical compositions comprising the same, and methods of their preparation and use of the same are disclosed herein.

Flame-retardant aconitic acid-derived monomers

A flame-retardant aconitic acid-derived monomer, a process for forming a flame-retardant polymer, and an article of manufacture comprising a material that contains a flame-retardant aconitic acid-derived monomer are disclosed. The flame-retardant aconitic acid-derived monomer can have at least one phosphoryl or phosphonyl moiety with functional groups that can participate in a polymerization reaction, such as allyl, epoxy, or propylene carbonate functional groups. The process for forming the flame-retardant polymer can include forming an aconitic acid derivative, forming a phosphorus-based flame-retardant molecule, and reacting the aconitic acid derivative with the phosphorus-based flame-retardant molecule to form a flame-retardant aconitic acid-derived monomer, which is then polymerized. The aconitic acid derivative can be synthesized from aconitic acid obtained from a bio-based source. The material in the article of manufacture can be a resin or adhesive, and the article of manufacture can further comprise an electronic component.

Functionalized flame-retardant aconitic acid-derived molecules

A functionalized flame-retardant aconitic acid-derived molecule, a process for forming a flame-retardant polymer, and an article of manufacture comprising a material that contains a functionalized flame-retardant aconitic acid-derived molecule are disclosed. The functionalized flame-retardant aconitic acid-derived molecule can have at least one phosphoryl or phosphonyl moiety with allyl functional groups, epoxy functional groups, propylene carbonate functional groups, or functionalized thioether substituents. The process for forming the flame-retardant polymer can include reacting an aconitic acid derivative with a flame-retardant phosphorus-based molecule to form a functionalized flame-retardant aconitic acid-derived molecule, and combining the functionalized flame-retardant aconitic acid-derived molecule with a polymer. The material in the article of manufacture can be a resin, plastic, polymer, or adhesive, and the article of manufacture can further comprise an electronic component.

Flame-retardant aconitic acid-derived cross-linkers

A flame-retardant aconitic acid-derived cross-linker, a process for forming a flame-retardant resin, and an article of manufacture comprising a material that contains a flame-retardant aconitic acid-derived cross-linker are disclosed. The flame-retardant aconitic acid-derived cross-linker can have at least two phosphoryl or phosphonyl moieties with allyl functional groups, epoxy functional groups, propylene carbonate functional group, or functionalized thioether substituents. The process for forming the flame-retardant polymer can include forming an aconitic acid derivative, forming a phosphorus-based flame-retardant molecule, and reacting the aconitic acid derivative with the phosphorus-based flame-retardant molecule to form a flame-retardant aconitic acid-derived cross-linker, and binding the cross-linker to a polymer. The aconitic acid derivative can be synthesized from aconitic acid obtained from a bio-based source. Examples of aconitic acid derivatives include carboxysuccinic acid, 2-(hydroxymethyl)-1,4-butenediol, and 2-(hydroxymethyl)-1,4-butanediol. The article of manufacture can further comprise an electronic component.